首页 > 最新文献

Neuroepidemiology最新文献

英文 中文
Rates and Impact of Serious Adverse Events after Endovascular Thrombectomy among Large Vessel Occlusion Stroke Patients. 大血管闭塞性卒中患者血管内血栓切除术后严重不良事件的发生率和影响。
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-08-12 DOI: 10.1159/000540555
Bo Lei, Shuang Yang, Ling Tian, Simin Zhou, Thanh N Nguyen, Mohamad K Abdalkader, Xing Liu, Yingbin Sun, Ning Zhao, Qin Han, An Mao, Zhaojun Tao, Yan Wang, Wenfeng Cao, Shiquan Yang, Jun Zhang, Fuqiang Guo, Hongbin Wen, Jinhua Zhang, Chengsong Yue, Jie Yang, Hongfei Sang, Zhongming Qiu, Ying Jin, Weidong Luo

Objective: Complications or serious adverse events (SAEs) are common in the treatment of patients with large vessel occlusion stroke. There has been limited study of the impact of SAEs for patients after endovascular thrombectomy (EVT). The goal of this study was to characterize the rates and clinical impact of SAEs following EVT.

Methods: A post hoc analysis was performed using pooled databases of the "DEVT" and "RESCUE BT" trials. SAEs were designated as symptomatic intracranial hemorrhage, brain herniation or craniectomy, respiratory failure, circulatory failure, pneumonia, deep venous thrombosis, and systemic bleeding. The primary endpoint was functional independence (modified Rankin scale score 0-2 within 90 days). Logistic regression analysis was used to determine the predictors and associations between SAEs and outcomes.

Results: Of 1,182 enrolled patients, 402 (34%) had a procedural complication and 745 (63%) had 1,404 SAE occurrences with 4.65% in-hospital mortality. The three most frequent SAEs were pneumonia (620, 52.5%), systemic bleeding (174, 14.7%), and respiratory failure (173, 14.6%). Pneumonia, systemic bleeding, or deep venous thrombosis was less life-threatening. Patients with advanced age (adjusted odds ratio, 1.28 [95% confidence interval, 1.14-1.43]), higher NIHSS (1.09 [1.06-1.11]), occlusion site (middle cerebral artery-M1 vs. internal carotid artery [ICA]: 0.75 [0.53-1.04]; M2 vs. ICA: 1.30 [0.80-2.12]), longer procedure time (1.01 [1.00-1.01]), and unsuccessful vessel recanalization (1.79 [1.06-2.94]) were more likely to experience SAEs. Compared with no SAE, patients with SAEs had lower odds of functional independence (0.46 [0.40-0.54]).

Conclusions: Overall, SAEs diagnosed following thrombectomy in patients with stroke were common (more than 60%) and associated with functional dependence. Patients with advanced age, higher NIHSS, longer procedure time, and failed recanalization were more likely to experience SAEs. There was no statistical difference in the risk of SAEs among patients with M1 and M2 occluded compared with those ICA occluded. An understanding of the prevalence and predictors of SAEs could alert clinicians to the estimated risk of an SAE for a patient after EVT.

目的 并发症或严重不良事件(SAE)在大血管闭塞性卒中患者的治疗中很常见。有关血管内血栓切除术(EVT)后 SAE 对患者影响的研究十分有限。本研究的目的是描述 EVT 后 SAE 的发生率和临床影响。方法 使用 "DEVT "和 "RESCUE BT "试验的汇总数据库进行事后分析。SAE包括无症状颅内出血、脑疝或颅骨切除、呼吸衰竭、循环衰竭、肺炎、深静脉血栓和全身出血。主要终点是功能独立性(90 天内改良兰金量表评分 0-2 分)。逻辑回归分析用于确定SAEs和结果之间的预测因素和关联。结果 在1182名入选患者中,402人(34%)发生了手术并发症,745人(63%)发生了1404例SAEs,院内死亡率为4.65%。最常见的三种 SAE 为肺炎(620 例,52.5%)、全身出血(174 例,14.7%)和呼吸衰竭(173 例,14.6%)。肺炎、全身出血或深静脉血栓对生命的威胁较小。高龄(调整后的几率比为 1.28 [95%置信区间,1.14-1.43])、NIHSS 较高(1.09 [1.06-1.11])、闭塞部位(大脑中动脉-M1 与颅内大脑动脉 [ICA]:0.75 [0.53-1.11])的患者死亡率较高:0.75[0.53-1.04];M2 vs. ICA:1.30[0.80-2.12])、手术时间较长(1.01[1.00-1.01])和血管再通术不成功(1.79[1.06-2.94])的患者更容易发生 SAE。与未发生 SAE 相比,发生 SAE 的患者功能独立的几率较低(0.46 [0.40-0.54])。结论 总体而言,脑卒中患者血栓切除术后确诊的 SAEs 很常见(超过 60%),且与功能依赖有关。高龄、NIHSS 较高、手术时间较长和再通失败的患者更容易发生 SAE。M1和M2闭塞患者发生SAE的风险与ICA闭塞患者相比没有统计学差异。了解SAE的发生率和预测因素可提醒临床医生EVT术后患者发生SAE的估计风险。
{"title":"Rates and Impact of Serious Adverse Events after Endovascular Thrombectomy among Large Vessel Occlusion Stroke Patients.","authors":"Bo Lei, Shuang Yang, Ling Tian, Simin Zhou, Thanh N Nguyen, Mohamad K Abdalkader, Xing Liu, Yingbin Sun, Ning Zhao, Qin Han, An Mao, Zhaojun Tao, Yan Wang, Wenfeng Cao, Shiquan Yang, Jun Zhang, Fuqiang Guo, Hongbin Wen, Jinhua Zhang, Chengsong Yue, Jie Yang, Hongfei Sang, Zhongming Qiu, Ying Jin, Weidong Luo","doi":"10.1159/000540555","DOIUrl":"10.1159/000540555","url":null,"abstract":"<p><strong>Objective: </strong>Complications or serious adverse events (SAEs) are common in the treatment of patients with large vessel occlusion stroke. There has been limited study of the impact of SAEs for patients after endovascular thrombectomy (EVT). The goal of this study was to characterize the rates and clinical impact of SAEs following EVT.</p><p><strong>Methods: </strong>A post hoc analysis was performed using pooled databases of the \"DEVT\" and \"RESCUE BT\" trials. SAEs were designated as symptomatic intracranial hemorrhage, brain herniation or craniectomy, respiratory failure, circulatory failure, pneumonia, deep venous thrombosis, and systemic bleeding. The primary endpoint was functional independence (modified Rankin scale score 0-2 within 90 days). Logistic regression analysis was used to determine the predictors and associations between SAEs and outcomes.</p><p><strong>Results: </strong>Of 1,182 enrolled patients, 402 (34%) had a procedural complication and 745 (63%) had 1,404 SAE occurrences with 4.65% in-hospital mortality. The three most frequent SAEs were pneumonia (620, 52.5%), systemic bleeding (174, 14.7%), and respiratory failure (173, 14.6%). Pneumonia, systemic bleeding, or deep venous thrombosis was less life-threatening. Patients with advanced age (adjusted odds ratio, 1.28 [95% confidence interval, 1.14-1.43]), higher NIHSS (1.09 [1.06-1.11]), occlusion site (middle cerebral artery-M1 vs. internal carotid artery [ICA]: 0.75 [0.53-1.04]; M2 vs. ICA: 1.30 [0.80-2.12]), longer procedure time (1.01 [1.00-1.01]), and unsuccessful vessel recanalization (1.79 [1.06-2.94]) were more likely to experience SAEs. Compared with no SAE, patients with SAEs had lower odds of functional independence (0.46 [0.40-0.54]).</p><p><strong>Conclusions: </strong>Overall, SAEs diagnosed following thrombectomy in patients with stroke were common (more than 60%) and associated with functional dependence. Patients with advanced age, higher NIHSS, longer procedure time, and failed recanalization were more likely to experience SAEs. There was no statistical difference in the risk of SAEs among patients with M1 and M2 occluded compared with those ICA occluded. An understanding of the prevalence and predictors of SAEs could alert clinicians to the estimated risk of an SAE for a patient after EVT.</p>","PeriodicalId":54730,"journal":{"name":"Neuroepidemiology","volume":" ","pages":"1-12"},"PeriodicalIF":3.2,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141972317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preconception Folic Acid and Multivitamin Supplementation for the Prevention of Neural Tube Defect: An Umbrella Review of Systematic Review and Meta-analysis. 孕前补充叶酸和多种维生素以预防神经管畸形:综述。
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-07-29 DOI: 10.1159/000539803
Biruk Beletew Abate, Henok Kumsa, Gebremeskel Abebe Kibret, Tilahun Wodaynew, Tesfaye Engdaw Habtie, Muluemebet Kassa, Melesse Abiye Munie, Dessie Temesgen, Befkad Derese Tilahun, Abebe Merchaw, Addis Wondimagegn Alamaw, Alemu Birara Zemariam, Tegene Atamenta Kitaw, Amare Kassaw, Ayelign Mengesha Kassie, Gizachew Yilak, Mulat Awoke Kassa, Fasikaw Kebede, Solomon Moges, Molalign Aligaz Adisu, Molla Azmeraw
<p><strong>Background: </strong>Previous reviews explored the association between maternal use of folic acid and multivitamin supplements and risk of neural tube defect (NTD) in children, with no definitive conclusion. These reviews had produced contradictory results, and there had been no umbrella review. Therefore, the objective of this umbrella review is to combine the inconsistent data on the effect of prenatal folic acid and/or multivitamin supplementation for the prevention of NTD in offspring.</p><p><strong>Methods: </strong>Using the PRISMA guideline, PubMed, Embase, Scopus, Web of Sciences, Cochrane Database of Systematic Reviews, Scopus, and Google Scholar reported that the effects of folic acid and/or multivitamin supplementation for the prevention of NTD in offspring were searched. The quality of the included studies was assessed using Assessment of Multiple Systematic Reviews (AMSTAR). A weighted inverse variance random-effects model was applied to find the pooled estimates. The subgroup analysis, heterogeneity, publication bias, and sensitivity analysis were also assessed.</p><p><strong>Result: </strong>Ten SRM with 296,816 study participants were included. The random-effects model analysis from 10 included systematic review and meta-analysis revealed that the pooled effect of either folic acid or multivitamin supplementation for the prevention of NTD globally is found to be 0.43 (95% CI: 0.29, 0.58) (I2 = 93.50%; p ≤0.001). In the subgroup analysis, the pooled effect was found to be 0.23 (0.09, 0.37) in folic acid group, while this estimate is 0.63 (0.53, 0.72) and 0.61 (0.46, 0.75) in groups who took multivitamin. The pooled effect of prevention of NTD was found to be 0.50 (0.34, 0.66) in SRMs aimed at occurrence prevention (primary prevention) group, while this estimate is 0.20 (-0.01, 0.41) among SRMs, which aimed at reoccurrence (secondary) prevention, and 0.61 (0.46, 0.75) among those SRMs aimed to assess the effect folic acid or multivitamin for the prevention of both occurrence and reoccurrence. The pooled effect of either folic acid or multivitamin supplementation for the prevention of NTD was found to be 0.45 (0.03, 0.87) in SRMs of observational studies, while this estimate is 0.43 (0.32, 0.54) among SRMs of randomized controlled trials.</p><p><strong>Conclusion: </strong>This umbrella review of systematic review and meta-analysis found that prenatal folic acid and/or multivitamin supplementation was associated with a 57% reduction in NTD. Participants who took folic acid supplementation were associated with a slightly higher (77%) percentage of reduction in NTD compared with those who took multivitamin (37%). Reductions of 80% and 50% were observed for reoccurrence and occurrence prevention of NTD. Reductions of 57% and 55% of NTD have been found in SRM of RCTs and observational studies. This umbrella review revealed that both folic acid and multivitamin were associated with significantly lower levels of NTD in children.
背景:以往的综述探讨了母亲服用叶酸和多种维生素补充剂与儿童神经管畸形(NTD)风险之间的关系,但没有得出明确的结论:采用PRISMA指南,检索了PubMed、Embase、Scopus、Web of Sciences、Cochrane系统综述数据库、Scopus和Google Scholar中报道叶酸和/或多种维生素补充剂对预防后代NTD有影响的研究。采用 "多重系统综述评估"(AMSTAR)对纳入研究的质量进行了评估。采用加权反方差随机效应模型得出汇总估计值。此外,还对亚组分析、异质性、发表偏倚和敏感性分析进行了评估:结果:共纳入了 10 项 SRM,296,816 名研究参与者。随机效应模型分析表明,补充叶酸或多种维生素对预防全球非淋菌性尿道炎的汇总效应为 0.43(0.29,0.58)。在亚组分析中,叶酸组的综合效果为 0.23,而服用多种维生素组的综合效果分别为 0.63 和 0.61。在以预防发生为目的的 SRM 中,预防 NTD 的汇总效应为 0.50,而在以预防再次发生为目的的 SRM 中,这一估计值为 0.20,在以评估叶酸或多种维生素对预防发生和再次发生的效果为目的的 SRM 中,这一估计值为 0.61。在观察性研究的 SRM 中,补充叶酸或多种维生素对预防 NTD 的综合效果为 0.45,而在随机对照试验的 SRM 中,这一估计值为 0.43:结论:产前补充叶酸和/或多种维生素可使NTD发病率降低57%。补充叶酸的受试者的 NTD 减少率略高(77%)。非畸形胎儿的复发率和预防率分别降低了 80% 和 50%。在 RCT 和观察性研究的 SRM 中发现,NTD 的减少率分别为 57% 和 55%。建议在孕前将这些营养补充剂纳入预防 NTD 的策略中。需要进行更大规模的前瞻性队列研究和研究性试验。
{"title":"Preconception Folic Acid and Multivitamin Supplementation for the Prevention of Neural Tube Defect: An Umbrella Review of Systematic Review and Meta-analysis.","authors":"Biruk Beletew Abate, Henok Kumsa, Gebremeskel Abebe Kibret, Tilahun Wodaynew, Tesfaye Engdaw Habtie, Muluemebet Kassa, Melesse Abiye Munie, Dessie Temesgen, Befkad Derese Tilahun, Abebe Merchaw, Addis Wondimagegn Alamaw, Alemu Birara Zemariam, Tegene Atamenta Kitaw, Amare Kassaw, Ayelign Mengesha Kassie, Gizachew Yilak, Mulat Awoke Kassa, Fasikaw Kebede, Solomon Moges, Molalign Aligaz Adisu, Molla Azmeraw","doi":"10.1159/000539803","DOIUrl":"10.1159/000539803","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Previous reviews explored the association between maternal use of folic acid and multivitamin supplements and risk of neural tube defect (NTD) in children, with no definitive conclusion. These reviews had produced contradictory results, and there had been no umbrella review. Therefore, the objective of this umbrella review is to combine the inconsistent data on the effect of prenatal folic acid and/or multivitamin supplementation for the prevention of NTD in offspring.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Using the PRISMA guideline, PubMed, Embase, Scopus, Web of Sciences, Cochrane Database of Systematic Reviews, Scopus, and Google Scholar reported that the effects of folic acid and/or multivitamin supplementation for the prevention of NTD in offspring were searched. The quality of the included studies was assessed using Assessment of Multiple Systematic Reviews (AMSTAR). A weighted inverse variance random-effects model was applied to find the pooled estimates. The subgroup analysis, heterogeneity, publication bias, and sensitivity analysis were also assessed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Result: &lt;/strong&gt;Ten SRM with 296,816 study participants were included. The random-effects model analysis from 10 included systematic review and meta-analysis revealed that the pooled effect of either folic acid or multivitamin supplementation for the prevention of NTD globally is found to be 0.43 (95% CI: 0.29, 0.58) (I2 = 93.50%; p ≤0.001). In the subgroup analysis, the pooled effect was found to be 0.23 (0.09, 0.37) in folic acid group, while this estimate is 0.63 (0.53, 0.72) and 0.61 (0.46, 0.75) in groups who took multivitamin. The pooled effect of prevention of NTD was found to be 0.50 (0.34, 0.66) in SRMs aimed at occurrence prevention (primary prevention) group, while this estimate is 0.20 (-0.01, 0.41) among SRMs, which aimed at reoccurrence (secondary) prevention, and 0.61 (0.46, 0.75) among those SRMs aimed to assess the effect folic acid or multivitamin for the prevention of both occurrence and reoccurrence. The pooled effect of either folic acid or multivitamin supplementation for the prevention of NTD was found to be 0.45 (0.03, 0.87) in SRMs of observational studies, while this estimate is 0.43 (0.32, 0.54) among SRMs of randomized controlled trials.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;This umbrella review of systematic review and meta-analysis found that prenatal folic acid and/or multivitamin supplementation was associated with a 57% reduction in NTD. Participants who took folic acid supplementation were associated with a slightly higher (77%) percentage of reduction in NTD compared with those who took multivitamin (37%). Reductions of 80% and 50% were observed for reoccurrence and occurrence prevention of NTD. Reductions of 57% and 55% of NTD have been found in SRM of RCTs and observational studies. This umbrella review revealed that both folic acid and multivitamin were associated with significantly lower levels of NTD in children.","PeriodicalId":54730,"journal":{"name":"Neuroepidemiology","volume":" ","pages":"1-14"},"PeriodicalIF":3.2,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141794121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mortality of Epilepsy in Chinese Populations: A Comprehensive Review. 中国人群的癫痫死亡率:全面回顾。
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-07-29 DOI: 10.1159/000540426
Xiaowen Zhou, Ding Ding, Wenzhi Wang, Dong Zhou, Josemir W Sander

Background: Premature mortality is a significant part of the epilepsy burden and may vary across populations, especially between high-income and lower- and middle-income countries. People with epilepsy in China are approximately a fifth of the global population with epilepsy. Previous studies were unlikely to represent the situation in China due to limitations in design, methods, sample size, follow-up time, and other inherent population heterogeneity.

Summary: By summarising the evidence on the mortality characteristics in Chinese populations with epilepsy in the last 6 decades, we found a median mortality rate of 14.7 (6.8-74.4)/1,000 person-years and a median standardised mortality ratio (SMR) of 4.4 (2.6-12.9) in population-based studies, and a median mortality rate of 12.3 (9.5-101.5)/1,000 person-years and a median SMR of 3.0 (1.5-5.1) in hospital-based studies. Vascular diseases, complications of diabetes, and accidental injuries were the leading causes of death. Risk factors for mortality were reported as older age, male, longer duration, and higher frequency of seizures. Case fatality ratios of status epilepticus in adults were higher than in children, and both increased with follow-up time. Mortality in people with symptomatic epilepsy was high and varied across different primary diseases.

Key messages: The highest mortality rate and sudden unexpected death in epilepsy (SUDEP) incidence were reported from the least developed areas in China. Accidental injuries were the most common causes of epilepsy-related deaths, while the incidence of SUDEP may be underestimated in Chinese populations. Further research is warranted to improve the understanding of premature mortality risk so that preventative measures can be introduced to improve the situation.

背景:过早死亡是癫痫负担的一个重要部分,不同人群的情况可能不同,尤其是在高收入国家和中低收入国家之间。中国的癫痫患者约占全球癫痫患者的五分之一。由于设计、方法、样本量、随访时间以及其他固有的人群异质性等方面的限制,以往的研究不太可能代表中国的情况。摘要:通过总结过去六十年中国癫痫患者死亡率特征的证据,我们发现中国癫痫患者的中位死亡率为 14.7(6.8-74.4)。7(6.8-74.4)/1000人年,中位标准化死亡率(SMR)为4.4(2.6-12.9);在基于医院的研究中,中位死亡率为12.3(9.5-101.5)/1000人年,中位SMR为3.0(1.5-5.1)。血管疾病、糖尿病并发症和意外伤害是导致死亡的主要原因。据报道,导致死亡的风险因素包括年龄较大、男性、持续时间较长以及癫痫发作频率较高。成人癫痫状态(SE)的病死率高于儿童,并且都随着随访时间的延长而增加。症状性癫痫患者的死亡率很高,不同原发性疾病的死亡率也不同:中国最不发达地区的死亡率和癫痫猝死(SUDEP)发生率最高。意外伤害是癫痫相关死亡的最常见原因,而中国人群中癫痫猝死的发生率可能被低估。为了更好地了解过早死亡的风险,以便采取预防措施来改善这一状况,有必要开展进一步的研究。
{"title":"Mortality of Epilepsy in Chinese Populations: A Comprehensive Review.","authors":"Xiaowen Zhou, Ding Ding, Wenzhi Wang, Dong Zhou, Josemir W Sander","doi":"10.1159/000540426","DOIUrl":"10.1159/000540426","url":null,"abstract":"<p><strong>Background: </strong>Premature mortality is a significant part of the epilepsy burden and may vary across populations, especially between high-income and lower- and middle-income countries. People with epilepsy in China are approximately a fifth of the global population with epilepsy. Previous studies were unlikely to represent the situation in China due to limitations in design, methods, sample size, follow-up time, and other inherent population heterogeneity.</p><p><strong>Summary: </strong>By summarising the evidence on the mortality characteristics in Chinese populations with epilepsy in the last 6 decades, we found a median mortality rate of 14.7 (6.8-74.4)/1,000 person-years and a median standardised mortality ratio (SMR) of 4.4 (2.6-12.9) in population-based studies, and a median mortality rate of 12.3 (9.5-101.5)/1,000 person-years and a median SMR of 3.0 (1.5-5.1) in hospital-based studies. Vascular diseases, complications of diabetes, and accidental injuries were the leading causes of death. Risk factors for mortality were reported as older age, male, longer duration, and higher frequency of seizures. Case fatality ratios of status epilepticus in adults were higher than in children, and both increased with follow-up time. Mortality in people with symptomatic epilepsy was high and varied across different primary diseases.</p><p><strong>Key messages: </strong>The highest mortality rate and sudden unexpected death in epilepsy (SUDEP) incidence were reported from the least developed areas in China. Accidental injuries were the most common causes of epilepsy-related deaths, while the incidence of SUDEP may be underestimated in Chinese populations. Further research is warranted to improve the understanding of premature mortality risk so that preventative measures can be introduced to improve the situation.</p>","PeriodicalId":54730,"journal":{"name":"Neuroepidemiology","volume":" ","pages":"1-14"},"PeriodicalIF":3.2,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141794120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Temporal Trends of Epilepsy in Children: A Retrospective Birth Cohort Study. 儿童癫痫的患病率和时间趋势:一项回顾性出生队列研究。
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-07-29 DOI: 10.1159/000540528
Bénédicte Driollet, Emmalin Buajitti, Asma M Ahmed, Jennifer A Hutcheon, Laura Rosella, Seungmi Yang

Objective: Epilepsy is one of the most common chronic neurologic diseases in children; however, few recent studies examine the prevalence of epilepsy and its evolution over time according to birth or maternal characteristics. The aim of the study was to examine the prevalence of epilepsy in children born between 2002 and 2020 and the temporal trends by year of birth, in Ontario, Canada, overall, and according to maternal and birth characteristics.

Methods: We included all in-hospital deliveries between 2002 and 2020 (N = 2,343,482) in Ontario, Canada, using linked administrative health dataset. We estimated the overall prevalence of epilepsy diagnosed before the age of 18 years, by birth and maternal characteristics. For temporal trend analyses, we restricted our population to children born up to 2012 (N = 1,405,271) and examined the prevalence of epilepsy diagnosed by age 8 by their year of birth, using Poisson regression.

Results: The overall prevalence of epilepsy in our cohort was 8.1 per 1,000 live births (95% CI: 8.0-8.2). Prevalence was higher for boys, for children born preterm, with congenital malformations, from multiple pregnancies, from mothers born in Canada, and for children living in deprived areas. Epilepsy prevalence diagnosed by age 8 increased slightly between 2002 and 2012 cohorts (6.9 [95% CI: 6.2-7.6] to 7.3 [95% CI: 6.6-8.1] per 1,000 live births, respectively). Differences by gestational age as gradient and socioeconomic characteristics were persistent and stable over time, while those by pregnancy plurality and sex decreased.

Significance: In a large population-based birth cohort in Canada, we observed a slight increase in epilepsy prevalence over time among children born in 2002 and those born in 2012 and persistent disparities by gestational age, socioeconomic position, and maternal immigration status. This study highlights the need for continued surveillance of rates to see if this increasing trend is persistent, to understand the potential causes behind it, and to understand the persistence of these disparities.

目的:癫痫是儿童最常见的慢性神经系统疾病之一:癫痫是儿童最常见的慢性神经系统疾病之一,然而,近期很少有研究根据出生或母亲特征来调查癫痫的患病率及其随时间的变化。目的:研究加拿大安大略省 2002 年至 2020 年间出生儿童的癫痫患病率,以及按出生年份、总体情况和产妇及出生特征划分的时间趋势:我们使用链接的行政健康数据集,纳入了加拿大安大略省 2002 年至 2020 年间的所有住院分娩(N=2 343 482)。我们按出生和产妇特征估算了 18 岁前确诊癫痫的总体患病率。为了进行时间趋势分析,我们将研究对象限定为2012年之前出生的儿童(N=1 405 271),并使用泊松回归法研究了8岁之前确诊的癫痫患病率与出生年份的关系:在我们的队列中,癫痫的总体患病率为每 1000 例活产中有 8.1 例(95% CI 8.0-8.2)。男孩、早产儿、先天畸形儿、多胎妊娠儿、出生在加拿大的母亲以及生活在贫困地区的儿童的患病率较高。在2002年和2012年的队列中,8岁前确诊的癫痫患病率略有上升(每1000名活产婴儿中的患病率分别从6.9(95% CI 6.2-7.6)上升到7.3(95% CI 6.6-8.1))。随着时间的推移,孕龄梯度和社会经济特征的差异持续存在并保持稳定,而妊娠多元化和性别差异则有所减小:在加拿大的一个基于人口的大型出生队列中,我们观察到 2002 年和 2012 年出生的儿童中癫痫患病率随着时间的推移略有上升,而且妊娠年龄、社会经济地位和母亲移民身份方面的差异持续存在。这项研究强调了继续监测患病率的必要性,以了解这一增长趋势是否持续,了解其背后的潜在原因,并了解这些差异的持续性。
{"title":"Prevalence and Temporal Trends of Epilepsy in Children: A Retrospective Birth Cohort Study.","authors":"Bénédicte Driollet, Emmalin Buajitti, Asma M Ahmed, Jennifer A Hutcheon, Laura Rosella, Seungmi Yang","doi":"10.1159/000540528","DOIUrl":"10.1159/000540528","url":null,"abstract":"<p><strong>Objective: </strong>Epilepsy is one of the most common chronic neurologic diseases in children; however, few recent studies examine the prevalence of epilepsy and its evolution over time according to birth or maternal characteristics. The aim of the study was to examine the prevalence of epilepsy in children born between 2002 and 2020 and the temporal trends by year of birth, in Ontario, Canada, overall, and according to maternal and birth characteristics.</p><p><strong>Methods: </strong>We included all in-hospital deliveries between 2002 and 2020 (N = 2,343,482) in Ontario, Canada, using linked administrative health dataset. We estimated the overall prevalence of epilepsy diagnosed before the age of 18 years, by birth and maternal characteristics. For temporal trend analyses, we restricted our population to children born up to 2012 (N = 1,405,271) and examined the prevalence of epilepsy diagnosed by age 8 by their year of birth, using Poisson regression.</p><p><strong>Results: </strong>The overall prevalence of epilepsy in our cohort was 8.1 per 1,000 live births (95% CI: 8.0-8.2). Prevalence was higher for boys, for children born preterm, with congenital malformations, from multiple pregnancies, from mothers born in Canada, and for children living in deprived areas. Epilepsy prevalence diagnosed by age 8 increased slightly between 2002 and 2012 cohorts (6.9 [95% CI: 6.2-7.6] to 7.3 [95% CI: 6.6-8.1] per 1,000 live births, respectively). Differences by gestational age as gradient and socioeconomic characteristics were persistent and stable over time, while those by pregnancy plurality and sex decreased.</p><p><strong>Significance: </strong>In a large population-based birth cohort in Canada, we observed a slight increase in epilepsy prevalence over time among children born in 2002 and those born in 2012 and persistent disparities by gestational age, socioeconomic position, and maternal immigration status. This study highlights the need for continued surveillance of rates to see if this increasing trend is persistent, to understand the potential causes behind it, and to understand the persistence of these disparities.</p>","PeriodicalId":54730,"journal":{"name":"Neuroepidemiology","volume":" ","pages":"1-11"},"PeriodicalIF":3.2,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141794135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations between Adipose Tissue-Specific Insulin Resistance and Atherosclerotic Plaques and Burden in Community-Based Population. 社区人群中脂肪组织特异性胰岛素抵抗与动脉粥样硬化斑块和负担之间的关系。
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-07-27 DOI: 10.1159/000540321
Qi Zhou, Xueli Cai, Aoming Jin, Jing Jing, Mengxing Wang, Suying Wang, Lerong Mei, Xia Meng, Shan Li, Tiemin Wei, Yongjun Wang, Liping Liu, Yuesong Pan

Background: We aimed to examine the association between adipose tissue-specific insulin resistance and atherosclerotic burden and plaques in intracranial, extracranial, and coronary arteries in community residents without diabetes.

Methods: Adipose tissue-specific insulin resistance index (Adipo-IR) was calculated by fasting serum insulin and free fatty acids and categorized into 4 groups according to the quartiles. The 3.0 T magnetic resonance imaging scanner was used to assess intracranial and extracranial atherosclerotic plaques, while computed tomography angiography was used to assess coronary atherosclerotic plaques. Intracranial, extracranial, and coronary atherosclerotic burden was assessed by segmental stenosis segment scores of the corresponding arterial segments, respectively. Binary and ordinal logistic regression models were utilized to investigate the relationship of Adipo-IR with the presence of atherosclerotic plaques and atherosclerotic burden.

Results: Of 2,719 participants (mean [standard deviation] age, 60.9 [6.6] years; 1,441 [53.0%] women), the prevalence of intracranial atherosclerotic plaques, extracranial atherosclerotic plaques, and coronary plaques were 432 (15.9%), 975 (35.9%), and 1,160 (42.7%), respectively. Compared with individuals with the lowest quartile, participants with the fourth quartile of the Adipo-IR were associated with intracranial atherosclerotic burden (common odds ratio [cOR]: 1.35; 95% confidence interval [CI]: 0.99-1.82), coronary plaque (odds ratio [OR]: 1.45; 95% CI: 1.15-1.83), and segment stenosis score (cOR: 1.44; 95% CI: 1.15-1.81) after adjustment for age, sex, and current smoking.

Conclusion: Adipose tissue-specific insulin resistance is associated with atherosclerotic burden and plaques in intracranial and coronary arteries in Chinese community nondiabetic residents.

背景:我们旨在研究未患糖尿病的社区居民的脂肪组织特异性胰岛素抵抗与颅内、颅外和冠状动脉的动脉粥样硬化负担和斑块之间的关系:通过空腹血清胰岛素和游离脂肪酸计算脂肪组织特异性胰岛素抵抗指数(Adipo-IR),并根据四分位数将其分为四组。3.0T磁共振成像(MRI)扫描仪用于评估颅内和颅外动脉粥样硬化斑块,而计算机断层扫描血管造影(CTA)用于评估冠状动脉粥样硬化斑块。颅内、颅外和冠状动脉粥样硬化负荷分别通过相应动脉节段的节段性狭窄分值进行评估。利用二元和序数逻辑回归模型研究了Adipo-IR与是否存在动脉粥样硬化斑块和动脉粥样硬化负荷的关系:在 2719 名参与者(平均 [SD] 年龄为 60.9 [6.6]岁;1441 [53.0%] 女性)中,颅内动脉粥样硬化斑块、颅外动脉粥样硬化斑块和冠状动脉斑块的发病率分别为 432(15.9%)、975(35.9%)和 1160(42.7%)。与最低四分位数的人相比,在对年龄、性别和目前吸烟情况进行调整后,脂肪组织特异性胰岛素指数第四四分位数的参与者与颅内动脉粥样硬化负担(常见几率比[cOR]:1.35;95% CI:0.99-1.82)、冠状动脉斑块(几率比[OR]:1.45;95% CI:1.15-1.83)和节段狭窄评分(cOR:1.44;95% CI:1.15-1.81)有关:结论:脂肪组织特异性胰岛素抵抗与中国社区非糖尿病居民颅内动脉和冠状动脉的动脉粥样硬化负荷和斑块有关。
{"title":"Associations between Adipose Tissue-Specific Insulin Resistance and Atherosclerotic Plaques and Burden in Community-Based Population.","authors":"Qi Zhou, Xueli Cai, Aoming Jin, Jing Jing, Mengxing Wang, Suying Wang, Lerong Mei, Xia Meng, Shan Li, Tiemin Wei, Yongjun Wang, Liping Liu, Yuesong Pan","doi":"10.1159/000540321","DOIUrl":"10.1159/000540321","url":null,"abstract":"<p><strong>Background: </strong>We aimed to examine the association between adipose tissue-specific insulin resistance and atherosclerotic burden and plaques in intracranial, extracranial, and coronary arteries in community residents without diabetes.</p><p><strong>Methods: </strong>Adipose tissue-specific insulin resistance index (Adipo-IR) was calculated by fasting serum insulin and free fatty acids and categorized into 4 groups according to the quartiles. The 3.0 T magnetic resonance imaging scanner was used to assess intracranial and extracranial atherosclerotic plaques, while computed tomography angiography was used to assess coronary atherosclerotic plaques. Intracranial, extracranial, and coronary atherosclerotic burden was assessed by segmental stenosis segment scores of the corresponding arterial segments, respectively. Binary and ordinal logistic regression models were utilized to investigate the relationship of Adipo-IR with the presence of atherosclerotic plaques and atherosclerotic burden.</p><p><strong>Results: </strong>Of 2,719 participants (mean [standard deviation] age, 60.9 [6.6] years; 1,441 [53.0%] women), the prevalence of intracranial atherosclerotic plaques, extracranial atherosclerotic plaques, and coronary plaques were 432 (15.9%), 975 (35.9%), and 1,160 (42.7%), respectively. Compared with individuals with the lowest quartile, participants with the fourth quartile of the Adipo-IR were associated with intracranial atherosclerotic burden (common odds ratio [cOR]: 1.35; 95% confidence interval [CI]: 0.99-1.82), coronary plaque (odds ratio [OR]: 1.45; 95% CI: 1.15-1.83), and segment stenosis score (cOR: 1.44; 95% CI: 1.15-1.81) after adjustment for age, sex, and current smoking.</p><p><strong>Conclusion: </strong>Adipose tissue-specific insulin resistance is associated with atherosclerotic burden and plaques in intracranial and coronary arteries in Chinese community nondiabetic residents.</p>","PeriodicalId":54730,"journal":{"name":"Neuroepidemiology","volume":" ","pages":"1-11"},"PeriodicalIF":3.2,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141789869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Gum Treatment with Cognitive Decline and Dementia Risk among Older Adults with Periodontal Symptoms: A 12-Year Prospective Cohort Study. 牙龈治疗与有牙周症状的老年人认知能力下降和痴呆症风险的关系:一项为期 12 年的前瞻性队列研究。
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-07-25 DOI: 10.1159/000540086
Xiang Qi, Zheng Zhu, Katherine Wang, Yaguang Zheng, An Li, Bei Wu

Introduction: This study examines the associations of gum treatment with cognitive decline and dementia risk among older adults with periodontal symptoms in the USA.

Methods: A cohort of 866 adults aged ≥50 with periodontal symptoms was recruited for the 2008 Health and Retirement Study "Dental Health Experimental Module" and followed until 2020. Cognitive function was assessed with the Telephone Interview for Cognitive Status (TICS). Dementia status was ascertained with the Langa-Weir algorithm based on TICS scores and proxy assessments. Linear mixed-effects model and multivariable Cox regression models were utilized to analyze the associations of gum treatment with cognitive decline and the risk of dementia, respectively.

Results: Of 866 participants (mean age 67.7, 61.4% women), 105 (12.1%) developed dementia with a median follow-up of 9 (IQR, 6-10) years. The dementia incidence rates were lower in the group with gum treatment (7.4 vs. 12.9 per 1,000 person-years). Compared with participants who did not have gum treatment, those with gum treatment experienced a decline in TICS score that was on average 0.025 (95% CI, 0.005-0.044) points less per year and a 38% lower incidence of dementia (hazard ratio, 0.62; 95% CI, 0.41-0.93). These associations were consistent across participants with a different severity of periodontal symptoms and sociodemographic characteristics (age, sex, race, ethnicity, and education) except for income levels.

Conclusion: Prompt gum treatment for older adults with periodontal symptoms may be beneficial for their cognitive health.

简介:本研究探讨了美国有牙周症状的老年人中牙龈治疗与认知能力下降和痴呆症风险之间的关系:本研究探讨了牙龈治疗与美国有牙周症状的老年人认知能力下降和痴呆症风险之间的关系:2008年健康与退休研究 "牙科健康实验模块 "招募了866名年龄≥50岁、有牙周症状的成年人,并对他们进行了跟踪调查,直至2020年。认知功能通过认知状况电话访谈(TICS)进行评估。根据 TICS 分数和代理评估结果,采用 Langa-Weir 算法确定痴呆状态。线性混合效应模型和多变量 Cox 回归模型分别用于分析口香糖治疗与认知能力下降和痴呆症风险之间的关系:在866名参与者(平均年龄67.7岁,61.4%为女性)中,有105人(12.1%)在中位数9年(IQR,6-10年)的随访期间患上了痴呆症。接受牙龈治疗组的痴呆症发病率较低(7.4 比 12.9‰)。与未接受牙龈治疗的参试者相比,接受牙龈治疗的参试者TICS评分平均每年下降0.025分(95% CI,0.005-0.044),痴呆症发病率降低38%(危险比,0.62;95% CI,0.41-0.93)。除收入水平外,这些关联在不同牙周症状严重程度和社会人口特征(年龄、性别、种族、民族和教育程度)的参与者中是一致的:结论:对有牙周症状的老年人及时进行牙龈治疗可能有益于他们的认知健康。
{"title":"Association of Gum Treatment with Cognitive Decline and Dementia Risk among Older Adults with Periodontal Symptoms: A 12-Year Prospective Cohort Study.","authors":"Xiang Qi, Zheng Zhu, Katherine Wang, Yaguang Zheng, An Li, Bei Wu","doi":"10.1159/000540086","DOIUrl":"10.1159/000540086","url":null,"abstract":"<p><strong>Introduction: </strong>This study examines the associations of gum treatment with cognitive decline and dementia risk among older adults with periodontal symptoms in the USA.</p><p><strong>Methods: </strong>A cohort of 866 adults aged ≥50 with periodontal symptoms was recruited for the 2008 Health and Retirement Study \"Dental Health Experimental Module\" and followed until 2020. Cognitive function was assessed with the Telephone Interview for Cognitive Status (TICS). Dementia status was ascertained with the Langa-Weir algorithm based on TICS scores and proxy assessments. Linear mixed-effects model and multivariable Cox regression models were utilized to analyze the associations of gum treatment with cognitive decline and the risk of dementia, respectively.</p><p><strong>Results: </strong>Of 866 participants (mean age 67.7, 61.4% women), 105 (12.1%) developed dementia with a median follow-up of 9 (IQR, 6-10) years. The dementia incidence rates were lower in the group with gum treatment (7.4 vs. 12.9 per 1,000 person-years). Compared with participants who did not have gum treatment, those with gum treatment experienced a decline in TICS score that was on average 0.025 (95% CI, 0.005-0.044) points less per year and a 38% lower incidence of dementia (hazard ratio, 0.62; 95% CI, 0.41-0.93). These associations were consistent across participants with a different severity of periodontal symptoms and sociodemographic characteristics (age, sex, race, ethnicity, and education) except for income levels.</p><p><strong>Conclusion: </strong>Prompt gum treatment for older adults with periodontal symptoms may be beneficial for their cognitive health.</p>","PeriodicalId":54730,"journal":{"name":"Neuroepidemiology","volume":" ","pages":"1-10"},"PeriodicalIF":3.2,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141762712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Waterpipe Tobacco Smoking and Multiple Sclerosis: A Systematic Review and Meta-Analysis. 吸食水烟与多发性硬化症:系统回顾与荟萃分析。
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-07-25 DOI: 10.1159/000540087
Elham Bazmi, Amir Hossein Behnoush, Moahmmad Taghi Talebian, Arya Afrooghe, Mohammad Ali Sahraian

Background: Multiple sclerosis (MS), as an autoimmune disease of the central nervous system, has a significant burden among people worldwide. Tobacco smoking is one of the most prevalent habits of patients with different diseases including those with MS, and among the methods of use, waterpipe tobacco smoking is gaining popularity. Herein, we aimed to systematically evaluate the association between waterpipe smoking and MS.

Methods: Relevant studies were identified to be included in this systematic review and meta-analysis through a systematic search in PubMed, Scopus, Web of Science, and Embase. Studies were screened by the title/abstract and then by their full text. Extraction of data was performed for relevant studies. Odds ratios (ORs) and their 95% confidence intervals (CIs) of the association between waterpipe smoking and MS were used to pool the results observed in each study.

Results: After the screening, a total of five studies were included in our systematic review, comprised of 3,087 individuals, among which there were 1,135 cases with MS. Random-effect meta-analysis revealed that ever-smoking waterpipe had a significant association with MS (OR: 1.73, 95% CI: 1.38-2.17, p value <0.0001). Similarly, past waterpipe smoking was significantly higher in those with MS, compared with controls (OR: 2.17, 95% CI: 1.61-2.92, p value <0.0001). Based on the reported results, smoking both tobacco and waterpipe had an additive association with MS. Finally, no association was found between the Expanded Disability Status Scale (EDSS) and waterpipe smoking.

Conclusion: Waterpipe as one of the common ways of tobacco smoking becoming popular has an association with MS, and even the use of waterpipe for a certain period in the lifetime has a significant correlation with MS. Further large-scale studies are needed to confirm these findings. These results could help clinicians in risk-stratifying the patients and to provide better care for the MS population.

背景:多发性硬化症(MS)是一种中枢神经系统(CNS)自身免疫性疾病,给全世界人民造成了沉重的负担。吸烟是包括多发性硬化症患者在内的各种疾病患者最普遍的生活习惯之一,而在各种吸烟方式中,水烟的使用越来越普遍。在此,我们旨在系统评估水烟与多发性硬化症之间的关系:方法:通过在 PubMed、Scopus、Web of Science 和 Embase 中进行系统检索,确定相关研究,并将其纳入本系统综述和荟萃分析。通过标题/摘要和全文对研究进行筛选。对相关研究进行了数据提取。使用吸烟水烟与多发性硬化症之间关系的比值比(OR)及其 95% 置信区间(CI)来汇总每项研究中观察到的结果:经过筛选,共有五项研究被纳入我们的系统综述,研究对象共 3087 人,其中多发性硬化症患者 1135 例。随机效应荟萃分析显示,曾经吸食水烟与多发性硬化症有显著相关性(OR 1.73,95% CI 1.38-2.17,P值为0.0001)。同样,与对照组相比,多发性硬化症患者过去吸食水烟的比例明显更高(OR 2.17,95% CI 1.61-2.92,p 值为 0.0001)。根据报告的结果,吸烟和水烟与多发性硬化症有叠加关系。最后,在扩展残疾状况量表(EDSS)与吸食水烟之间未发现任何关联:结论:水烟作为流行的常见吸烟方式之一,与多发性硬化症有一定的联系,甚至在一生中的某个时期使用水烟也与多发性硬化症有显著的相关性。需要进一步的大规模研究来证实这些发现。这些结果有助于临床医生对患者进行风险分级,为多发性硬化症患者提供更好的治疗。
{"title":"Waterpipe Tobacco Smoking and Multiple Sclerosis: A Systematic Review and Meta-Analysis.","authors":"Elham Bazmi, Amir Hossein Behnoush, Moahmmad Taghi Talebian, Arya Afrooghe, Mohammad Ali Sahraian","doi":"10.1159/000540087","DOIUrl":"10.1159/000540087","url":null,"abstract":"<p><strong>Background: </strong>Multiple sclerosis (MS), as an autoimmune disease of the central nervous system, has a significant burden among people worldwide. Tobacco smoking is one of the most prevalent habits of patients with different diseases including those with MS, and among the methods of use, waterpipe tobacco smoking is gaining popularity. Herein, we aimed to systematically evaluate the association between waterpipe smoking and MS.</p><p><strong>Methods: </strong>Relevant studies were identified to be included in this systematic review and meta-analysis through a systematic search in PubMed, Scopus, Web of Science, and Embase. Studies were screened by the title/abstract and then by their full text. Extraction of data was performed for relevant studies. Odds ratios (ORs) and their 95% confidence intervals (CIs) of the association between waterpipe smoking and MS were used to pool the results observed in each study.</p><p><strong>Results: </strong>After the screening, a total of five studies were included in our systematic review, comprised of 3,087 individuals, among which there were 1,135 cases with MS. Random-effect meta-analysis revealed that ever-smoking waterpipe had a significant association with MS (OR: 1.73, 95% CI: 1.38-2.17, p value &lt;0.0001). Similarly, past waterpipe smoking was significantly higher in those with MS, compared with controls (OR: 2.17, 95% CI: 1.61-2.92, p value &lt;0.0001). Based on the reported results, smoking both tobacco and waterpipe had an additive association with MS. Finally, no association was found between the Expanded Disability Status Scale (EDSS) and waterpipe smoking.</p><p><strong>Conclusion: </strong>Waterpipe as one of the common ways of tobacco smoking becoming popular has an association with MS, and even the use of waterpipe for a certain period in the lifetime has a significant correlation with MS. Further large-scale studies are needed to confirm these findings. These results could help clinicians in risk-stratifying the patients and to provide better care for the MS population.</p>","PeriodicalId":54730,"journal":{"name":"Neuroepidemiology","volume":" ","pages":"1-11"},"PeriodicalIF":3.2,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141762713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between Physical Activity and Parkinson's Disease: A Prospective Cohort Study. 体育锻炼与帕金森病的关系:前瞻性队列研究
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-07-22 DOI: 10.1159/000540397
Qilu Zhang, Mengyao Shi, Jing Zhang, Xiangyan Yin, Yi Chen, Xiaoxiao Wang, Yonghong Zhang

Background: The burden of Parkinson's disease (PD) is still increasing, and physical activity is a modifiable factor for health benefits. The benefits of physical activity in PD are not well established. Therefore, this study aimed to investigate the association between various types of physical activity and the risk of developing PD.

Methods: Data from 432,497 participants in UK Biobank, who were free of PD at baseline, were analyzed. Physical activity levels were assessed by measuring the duration of walking for pleasure, light and heavy do-it-yourself (DIY) activities, strenuous sports, and other exercises. Physical activity was categorized into daily living activities (walking for pleasure, light DIY, and heavy DIY) and structured exercises (strenuous sports and other exercises). Association between different types of physical activity and PD risk was examined using multivariable adjusted restricted cubic splines and Cox proportional risk models.

Results: Over a median follow-up of 13.7 years, 2,350 PD cases were identified. Cubic spline analyses revealed negative linear associations between PD risk and total physical activity, daily living activities, and structured exercise. After multivariable adjustment, the hazard ratios and 95% confidence intervals for incident PD associated with the highest quartile of total physical activity, daily living activities, and structured exercise were 0.72 (0.64-0.81), 0.75 (0.67-0.84), and 0.78 (0.67-0.90), respectively, compared to those in the lowest quartile. Sensitivity analysis confirmed these findings.

Conclusions: Higher levels of both daily living activities and structured exercise were associated with a reduced incidence of PD, underscoring the importance of maintaining physical activity to prevent PD.

背景:帕金森病(Parkinson's disease,PD)的发病率仍在上升,而体育锻炼是一个可改变健康状况的因素。体育锻炼对帕金森病的益处尚未得到充分证实。因此,本研究旨在调查各种类型的体育锻炼与帕金森病发病风险之间的关系:方法:分析了英国生物库中 432,497 名参与者的数据,这些参与者在基线时均未患有帕金森病。体力活动水平是通过测量快乐步行、轻度和重度DIY活动、剧烈运动和其他锻炼的持续时间来评估的。体力活动分为日常生活活动(散步消遣、轻度 DIY 和重度 DIY)和结构性锻炼(剧烈运动和其他锻炼)。采用多变量调整限制性三次样条模型和 Cox 比例风险模型对不同类型的体力活动与帕金森病风险之间的关系进行了研究:结果:在中位 13.7 年的随访中,共发现了 2350 例脊髓灰质炎病例。立方样条分析表明,帕金森病风险与总体力活动、日常生活活动和结构化锻炼之间存在负线性关系。经多变量调整后,与总体力活动、日常生活活动和结构化锻炼的最高四分位数相比,发生脊髓灰质炎的危险比和95%置信区间分别为0.72(0.64-0.81)、0.75(0.67-0.84)和0.78(0.67-0.90),与最低四分位数相比,发生脊髓灰质炎的危险比和95%置信区间分别为0.72(0.64-0.81)、0.75(0.67-0.84)和0.78(0.67-0.90)。敏感性分析证实了这些结果:结论:较高水平的日常生活活动和有组织的锻炼与帕金森病发病率的降低有关,强调了保持体育锻炼对预防帕金森病的重要性。
{"title":"Association between Physical Activity and Parkinson's Disease: A Prospective Cohort Study.","authors":"Qilu Zhang, Mengyao Shi, Jing Zhang, Xiangyan Yin, Yi Chen, Xiaoxiao Wang, Yonghong Zhang","doi":"10.1159/000540397","DOIUrl":"10.1159/000540397","url":null,"abstract":"<p><strong>Background: </strong>The burden of Parkinson's disease (PD) is still increasing, and physical activity is a modifiable factor for health benefits. The benefits of physical activity in PD are not well established. Therefore, this study aimed to investigate the association between various types of physical activity and the risk of developing PD.</p><p><strong>Methods: </strong>Data from 432,497 participants in UK Biobank, who were free of PD at baseline, were analyzed. Physical activity levels were assessed by measuring the duration of walking for pleasure, light and heavy do-it-yourself (DIY) activities, strenuous sports, and other exercises. Physical activity was categorized into daily living activities (walking for pleasure, light DIY, and heavy DIY) and structured exercises (strenuous sports and other exercises). Association between different types of physical activity and PD risk was examined using multivariable adjusted restricted cubic splines and Cox proportional risk models.</p><p><strong>Results: </strong>Over a median follow-up of 13.7 years, 2,350 PD cases were identified. Cubic spline analyses revealed negative linear associations between PD risk and total physical activity, daily living activities, and structured exercise. After multivariable adjustment, the hazard ratios and 95% confidence intervals for incident PD associated with the highest quartile of total physical activity, daily living activities, and structured exercise were 0.72 (0.64-0.81), 0.75 (0.67-0.84), and 0.78 (0.67-0.90), respectively, compared to those in the lowest quartile. Sensitivity analysis confirmed these findings.</p><p><strong>Conclusions: </strong>Higher levels of both daily living activities and structured exercise were associated with a reduced incidence of PD, underscoring the importance of maintaining physical activity to prevent PD.</p>","PeriodicalId":54730,"journal":{"name":"Neuroepidemiology","volume":" ","pages":"1-8"},"PeriodicalIF":3.2,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141749785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Family History of Stroke Is Associated with Large- and Small-Vessel Etiology: A Systematic Review and Meta-Analysis. 中风家族史与大血管和小血管病因相关:系统回顾和荟萃分析。
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-07-22 DOI: 10.1159/000540085
Michał Błaż, Iwona Sarzyńska-Długosz

Background: Several studies have investigated the association between family history of stroke (FHS) and stroke etiology, recurrence, or mortality; however, the results have been discrepant. We conducted a systematic review with meta-analysis to further evaluate the associations.

Materials and methods: We searched Scopus database using the term "family history" AND "stroke" up to December 2023 to identify observational studies and systematic reviews reporting both the prevalence of FHS and the rates of stroke etiology or recurrence or mortality. Case reports, series, and narrative reviews were excluded. We used odds ratio (OR) as a common measure of association and I2 to determine heterogeneity of effects across studies.

Results: We have identified 22 articles (130,999 patients, 53% female), which met the prespecified inclusion criteria. After pooling the results, FHS was associated with large-vessel (OR, 1.24, 95% CI [1.07-1.44]), as well as small-vessel (OR, 1.17, 95% CI [1.05-1.31]), but not cardioembolic stroke etiology (OR, 0.74, 95% CI [0.60-0.90]). There was no relationship between FHS and stroke recurrence (OR, 1.16, 96% CI [0.84-1.61]), nor mortality (0.94, 95% CI [0.63-1.41]).

Conclusions: FHS is associated with large- and small-vessel stroke etiology, but not stroke recurrence or mortality. These findings might be useful to physicians caring for stroke patients in their everyday practice.

背景:有多项研究调查了卒中家族史(FHS)与卒中病因、复发或死亡率之间的关系,但结果并不一致。我们进行了一项荟萃分析系统综述,以进一步评估二者之间的关联:我们在 Scopus 数据库中使用 "家族史 "和 "卒中 "这两个词进行了检索,检索时间截至 2023 年 12 月,目的是找出报道家族史患病率和卒中病因、复发率或死亡率的观察性研究和系统综述。病例报告、系列研究和叙述性综述均被排除在外。我们使用几率比作为衡量关联性的通用指标,并使用 I2 来确定各研究间效应的异质性:我们确定了 22 篇文章(130 999 名患者,53% 为女性)符合预先规定的纳入标准。汇总结果后,FHS 与大血管(OR,1.24,95%CI [1.07-1.44])和小血管(OR,1.17,95%CI [1.05-1.31])相关,但与心肌栓塞性卒中病因无关(OR,0.74,95%CI [0.60-0.90])。FHS与中风复发(OR,1.16,96%CI [0.84-1.61])和死亡率(0.94,95%CI [0.63-1.41])之间没有关系:结论:FHS 与大血管和小血管卒中病因有关,但与卒中复发或死亡率无关。结论:FHS 与大血管和小血管卒中病因有关,但与卒中复发或死亡率无关。这些发现可能对日常护理卒中患者的医生有用。
{"title":"Family History of Stroke Is Associated with Large- and Small-Vessel Etiology: A Systematic Review and Meta-Analysis.","authors":"Michał Błaż, Iwona Sarzyńska-Długosz","doi":"10.1159/000540085","DOIUrl":"10.1159/000540085","url":null,"abstract":"<p><strong>Background: </strong>Several studies have investigated the association between family history of stroke (FHS) and stroke etiology, recurrence, or mortality; however, the results have been discrepant. We conducted a systematic review with meta-analysis to further evaluate the associations.</p><p><strong>Materials and methods: </strong>We searched Scopus database using the term \"family history\" AND \"stroke\" up to December 2023 to identify observational studies and systematic reviews reporting both the prevalence of FHS and the rates of stroke etiology or recurrence or mortality. Case reports, series, and narrative reviews were excluded. We used odds ratio (OR) as a common measure of association and I2 to determine heterogeneity of effects across studies.</p><p><strong>Results: </strong>We have identified 22 articles (130,999 patients, 53% female), which met the prespecified inclusion criteria. After pooling the results, FHS was associated with large-vessel (OR, 1.24, 95% CI [1.07-1.44]), as well as small-vessel (OR, 1.17, 95% CI [1.05-1.31]), but not cardioembolic stroke etiology (OR, 0.74, 95% CI [0.60-0.90]). There was no relationship between FHS and stroke recurrence (OR, 1.16, 96% CI [0.84-1.61]), nor mortality (0.94, 95% CI [0.63-1.41]).</p><p><strong>Conclusions: </strong>FHS is associated with large- and small-vessel stroke etiology, but not stroke recurrence or mortality. These findings might be useful to physicians caring for stroke patients in their everyday practice.</p>","PeriodicalId":54730,"journal":{"name":"Neuroepidemiology","volume":" ","pages":"1-7"},"PeriodicalIF":3.2,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141749786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diverging Trends in Survival and Functional Outcome between Males and Females after Intracerebral Hemorrhage. 男性和女性在脑出血后的存活率和功能预后方面的不同趋势。
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-07-22 DOI: 10.1159/000539958
Trine Apostolaki-Hansson, Christine Kremer, Mats Pihlsgård, Jesper Petersson, Bo Norrving, Teresa Ullberg

Background: Compared to ischemic stroke, sex differences in patient outcomes following intracerebral hemorrhage (ICH) are underreported. We aimed to determine sex differences in mortality and functional outcomes in a large, unselected Swedish cohort.

Methods: In this observational study, data on 22,789 patients with spontaneous ICH registered in the Swedish Stroke Register between 2012 and 2019 were used to compare sex differences in 90-day mortality and functional outcome using multivariable Cox and logistic regression analyses, adjusting for relevant confounders. Multiple imputation was used to impute missing data.

Results: The crude 90-day mortality rate was 36.7% in females (3,820/10,405) and 31.7% in males (3,929/12,384) (female hazard ratio [HR] 1.20 95% confidence interval [CI]: 1.15-1.25). In multivariable analysis, the HR for 90-day mortality following ICH in females was 0.89 (95% CI: 0.85-0.94). Age was an important driving factor for the effect of sex on mortality. After adjustment for age, vascular risk factors, and stroke severity, the 90-day functional outcome in pre-stroke independent patients was worse in females compared to males (odds ratio: 1.27 95% CI: 1.16-1.40).

Conclusion: In this large observational study, despite lower 90-day mortality, the female sex was independently associated with a worse functional outcome compared to males after ICH, even after adjusting for significant covariates. These diverging trends have not been previously reported for ICH. Given the observational design, our findings should be interpreted with caution, thus further external validation is warranted.

背景与缺血性中风相比,脑内出血 (ICH) 患者预后的性别差异未得到充分报道。我们的目的是在一个未经选择的瑞典大型队列中确定死亡率和功能预后的性别差异。方法 在这项观察性研究中,我们使用瑞典卒中登记中心在 2012-2019 年间登记的 22789 例自发性 ICH 患者的数据,在调整相关混杂因素后,使用多变量 Cox 和逻辑回归分析比较 90 天死亡率和功能预后的性别差异。采用多重估算法对缺失数据进行估算。结果 女性的粗略 90 天死亡率为 36.7%(3820/10405),男性为 31.7%(3929/12384)(女性危险比 (HR) 1.20 95%CI: 1.15-1.25)。在多变量分析中,女性 ICH 90 天死亡率的危险比为 0.89(95%CI:0.85-0.94)。年龄是性别影响死亡率的重要驱动因素。调整年龄、血管风险因素和卒中严重程度后,女性卒中前独立患者的 90 天功能预后比男性差(OR 1.27 95%CI:1.16-1.40)。结论 在这项大型观察性研究中,尽管女性患者的 90 天死亡率较低,但与男性患者相比,女性患者在 ICH 后的功能预后较差,即使在调整了重要的协变量后也是如此。这些不同的趋势以前从未在 ICH 中报道过。鉴于我们的研究采用的是观察性设计,因此在解释我们的研究结果时应谨慎,还需要进一步的外部验证。
{"title":"Diverging Trends in Survival and Functional Outcome between Males and Females after Intracerebral Hemorrhage.","authors":"Trine Apostolaki-Hansson, Christine Kremer, Mats Pihlsgård, Jesper Petersson, Bo Norrving, Teresa Ullberg","doi":"10.1159/000539958","DOIUrl":"10.1159/000539958","url":null,"abstract":"<p><strong>Background: </strong>Compared to ischemic stroke, sex differences in patient outcomes following intracerebral hemorrhage (ICH) are underreported. We aimed to determine sex differences in mortality and functional outcomes in a large, unselected Swedish cohort.</p><p><strong>Methods: </strong>In this observational study, data on 22,789 patients with spontaneous ICH registered in the Swedish Stroke Register between 2012 and 2019 were used to compare sex differences in 90-day mortality and functional outcome using multivariable Cox and logistic regression analyses, adjusting for relevant confounders. Multiple imputation was used to impute missing data.</p><p><strong>Results: </strong>The crude 90-day mortality rate was 36.7% in females (3,820/10,405) and 31.7% in males (3,929/12,384) (female hazard ratio [HR] 1.20 95% confidence interval [CI]: 1.15-1.25). In multivariable analysis, the HR for 90-day mortality following ICH in females was 0.89 (95% CI: 0.85-0.94). Age was an important driving factor for the effect of sex on mortality. After adjustment for age, vascular risk factors, and stroke severity, the 90-day functional outcome in pre-stroke independent patients was worse in females compared to males (odds ratio: 1.27 95% CI: 1.16-1.40).</p><p><strong>Conclusion: </strong>In this large observational study, despite lower 90-day mortality, the female sex was independently associated with a worse functional outcome compared to males after ICH, even after adjusting for significant covariates. These diverging trends have not been previously reported for ICH. Given the observational design, our findings should be interpreted with caution, thus further external validation is warranted.</p>","PeriodicalId":54730,"journal":{"name":"Neuroepidemiology","volume":" ","pages":"1-11"},"PeriodicalIF":3.2,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141565036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Neuroepidemiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1